Epilepsy, Complex Partial - 14 Studies Found
| Recruiting |
: Bioavailability, Safety, and Tolerability of BIS-001 ER : Epilepsy, Complex Partial : 2017-05-15 : Drug: BIS-001 ER BIS-001 ER is an extended release formulation of the nutritional supplement Huperzine A |
| Completed |
: A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 : Epilepsy, Complex Partial : 2009-10-16 : Drug: ganaxolone liquid suspension, 50 mg/mL, up to 500 mg/day TID or 1500 mg/day, up to 1 year |
| Completed |
: Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy : Epilepsy, Complex Partial : 2003-03-18 : Drug: Zonisamide |
| Completed |
: Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin : Epilepsy, Complex Partial : 2010-05-20 :
|
| Completed |
: Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism :
: 1999-11-03 |
| Completed |
: Pregabalin Open-Label Extension Trial in Patients With Partial Seizures :
: 2005-08-30 : Drug: Pregabalin |
| Completed |
: An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures. :
|
| Completed |
: An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures :
: |
| Completed |
: A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures. :
: |
| Completed |
: A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. :
|